Carlos D. Serrano-Reyes

Cali, VAC, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol After Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study.

Clinical Performance of a Standardized Two-Step Drug Provocation Test Protocol After Retrospective Application of the EAACI/ENDA 2024 Risk Stratification: A Real-World Cohort Study.

Journal: International archives of allergy and immunology

Published: April 14, 2026

Discontinuation of biologic therapy in severe asthma: Evidence and strategies for safe withdrawal: A scoping review.

Discontinuation of biologic therapy in severe asthma: Evidence and strategies for safe withdrawal: A scoping review.

Journal: The World Allergy Organization journal

Published: May 30, 2025

Latin American guidelines for the diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Latin American guidelines for the diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Journal: The World Allergy Organization journal

Published: July 29, 2024

Single center experience with more than 600 drug desensitization in Colombia.

Single center experience with more than 600 drug desensitization in Colombia.

Journal: Frontiers in allergy

Published: July 05, 2024

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Multicentric and Observational Study of Omalizumab for Chronic Spontaneous Urticaria in Real-Life in Colombia.

Journal: Frontiers in allergy

Published: March 23, 2022

Meloxicam and/or Etoricoxib Could Be Administered Safely in Two Equal Doses during an Open Oral Challenge in Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.

Meloxicam and/or Etoricoxib Could Be Administered Safely in Two Equal Doses during an Open Oral Challenge in Patients with Nonsteroidal Anti-Inflammatory Drug Hypersensitivity.

Journal: International archives of allergy and immunology

Published: August 08, 2020

Descriptive Analysis of Cross-Reactive Anaphylaxis as a Different Clinical Subtype of Nonsteroidal Anti-Inflammatory Drug (NSAID) Hypersensitivity.

Descriptive Analysis of Cross-Reactive Anaphylaxis as a Different Clinical Subtype of Nonsteroidal Anti-Inflammatory Drug (NSAID) Hypersensitivity.

Journal: International archives of allergy and immunology

Published: June 29, 2020

Descriptive analysis of a simplified approach to low-risk drug hypersensitivity reactions.

Descriptive analysis of a simplified approach to low-risk drug hypersensitivity reactions.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: June 29, 2020

Flagellate dermatitis caused by the intake of shiitake mushrooms. A case report and review of the literature

Flagellate dermatitis caused by the intake of shiitake mushrooms. A case report and review of the literature

Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)

Published: May 25, 2020

Severe Cutaneous Adverse Reactions to Drugs in Latin America: The RACGRAD Study.

Severe Cutaneous Adverse Reactions to Drugs in Latin America: The RACGRAD Study.

Journal: Journal of investigational allergology & clinical immunology

Published: February 27, 2020

Mutant GNLY is linked to Stevens-Johnson syndrome and toxic epidermal necrolysis.

Mutant GNLY is linked to Stevens-Johnson syndrome and toxic epidermal necrolysis.

Journal: Human genetics

Published: July 11, 2019

Drug-induced anaphylaxis, elicitors, risk factors, and management in Latin America.

Drug-induced anaphylaxis, elicitors, risk factors, and management in Latin America.

Journal: The journal of allergy and clinical immunology. In practice

Published: May 05, 2019

Showing 1-12 of 15

Last Updated: 09/26/2026